Search - tctmd.com

Displaying 181 - 200 of 216

Sort: Relevancy | Date

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

Presentation ACVS 2012

Bivalirudin Versus Heparin in STEMI

Presenter: Colonel Anil Dhall

August 03, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

July 05, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

Presentation

PHARAOH: Effect of A Priori vs. Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Presenter: Samir B. Pancholy

April 26, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

April 03, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

March 07, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

Presentation TCT 2012

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

Presenter: James W. Wisler, Jeffrey B. Washam, Richard C. Becker

January 03, 2012

Presentation TCT 2012

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Presenter: Martial Hamon

January 03, 2012

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

Advertisement

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Bivalirudin Versus Heparin in STEMI

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

PHARAOH: Effect of A Priori vs. Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

PRODIGY Published: No Advantage to Long-term Clopidogrel

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

Comparison of bivalirudin versus heparin during PCI in patients receiving prasugrel M Hamon, S Marso, SV Rao, M Valgimigli, F Verheugt, A Gershlick, Y Wang, GP Steg, E...

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content